Met Life Investment Management, LLC Sight Sciences, Inc. Transaction History

Met Life Investment Management, LLC

  • $14.7 Billion
  • Q1 2024

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Apr 29, 2024
BUY
$7.46 - $10.67 $91,131 - $130,344
12,216 New
12,216 $101,000
Q1 2023

May 09, 2024
BUY
$8.44 - $13.35 $103,103 - $163,083
12,216 New
12,216 $107 Million
Q4 2022

May 10, 2024
SELL
$5.58 - $13.94 $11,985 - $29,943
-2,148 Reduced 14.95%
12,216 $149,000
Q4 2022

Mar 22, 2023
SELL
$5.58 - $13.94 $11,985 - $29,943
-2,148 Reduced 14.95%
12,216 $149,000
Q4 2022

Feb 15, 2023
BUY
$5.58 - $13.94 $68,165 - $170,291
12,216 New
12,216 $149,000
Q2 2022

Jun 20, 2023
BUY
$6.61 - $11.99 $14,198 - $25,754
2,148 Added 17.58%
14,364 $129,000
Q1 2022

May 10, 2024
BUY
$11.56 - $17.9 $166,047 - $257,115
14,364 New
14,364 $166,000
Q1 2022

Jun 20, 2023
BUY
$11.56 - $17.9 $24,830 - $38,449
2,148 Added 17.58%
14,364 $166,000
Q1 2022

Mar 22, 2023
BUY
$11.56 - $17.9 $111,288 - $172,323
9,627 Added 203.23%
14,364 $166,000
Q1 2022

May 12, 2022
BUY
$11.56 - $17.9 $166,047 - $257,115
14,364 New
14,364 $166,000
Q4 2021

Feb 15, 2022
SELL
$17.36 - $27.36 $82,234 - $129,604
-4,737 Closed
0 $0
Q3 2021

May 17, 2024
BUY
$22.34 - $39.1 $105,824 - $185,216
4,737 New
4,737 $107,000
Q3 2021

Jun 21, 2023
SELL
$22.34 - $39.1 $167,080 - $292,428
-7,479 Reduced 61.22%
4,737 $107,000
Q3 2021

Mar 22, 2023
SELL
$22.34 - $39.1 $167,080 - $292,428
-7,479 Reduced 61.22%
4,737 $107,000
Q3 2021

Nov 15, 2021
BUY
$22.34 - $39.1 $105,824 - $185,216
4,737 New
4,737 $108,000

Others Institutions Holding SGHT

# of Institutions
69
Shares Held
21.1M
Call Options Held
33.2K
Put Options Held
27.7K
View Full List

About Sight Sciences, Inc.

SGHT Quotes by TradingView
  • Ticker SGHT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 47,826,200
  • Market Cap $297M
  • Description
  • Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; a...
More about SGHT
Track This Portfolio

Track Met Life Investment Management, LLC Portfolio

Follow Met Life Investment Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Met Life Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Met Life Investment Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email